Genes and miRNAs involved in sarcomagenesis related pathways are unknown and therefore signaling events leading to mesenchymal cell transformation to sarcoma are poorly elucidated. Exiqon and Illumina microarray study on human chondrosarcoma JJ012 and chondrocytes C28 cell lines to compare and analyze the differentially expressed miRNAs and their gene targets was recently published in the Journal Tumor Biology in 2014. Here we describe in details the contents and quality controls for the miRNA and gene expression data associated with the study that is relevant to this dataset.
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Direct link to deposited data
Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE48420.
Experimental design, materials and methods

Study cell line data
Human chondrosarcoma (JJ012) and chrondrocytes (C28) cell lines were obtained from the University of Miami Tissue bank and cultured in monolayer until they were semiconfluent as described previously [1, 2] . Cells were lysed and 100 μg of total RNA from the sample was prepared using the Qiagen RNeasy mini kit. NanoDrop 8000 spectrometer was used to check for RNA integrity and the presence of small RNA fractions was determined using Agilent Bioanalyzer 2100.
miRNA expression data 20 ng of total RNA per panel was reverse transcribed using the miRCURY LNA™ Universal RT microRNA PCR and polyadenylation and cDNA synthesis kit (Exiqon, Woburn, MA). For each sample, the cDNA was diluted, and each reaction was combined with SYBR Green Master Mix (Exiqon) and added to the Ready-to-Use PCR panels. Human microRNA Ready-to-Use PCR panels I and II hold 743 different miRNA targets and six reference gene assays (mirBase13). They were tested on a Roche LightCycler 480 realtime PCR instrument. 
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Quality control
We used the GenEx version 5 software from MultiD Analyses AB to analyze the RT-PCR data of the human miRNAs. Layout files for human panels I and II version 2 with miRBase 16 annotations was loaded on the software. miRNA expression data was imported and sample and group classification columns were appropriately modified to define the replicates. The groups were labeled as 'SARC' for human chondrosarcoma and 'C28' for chondrocytes. The data was pre-processed as provided by the software guidelines. Interplate calibration was performed using mean values between plates. Outlier data points were deleted from analysis using Grubb's test on replicates with default confidence level (0.95) and cut-off SD (0.25). All values which were larger than 37 (default) were replaced with a blank and all empty rows and undetected miRNAs were removed. Missing 'NaN' values were also replaced and the data was validated to remove data points for miRNAs which had less than 75% values from replicates within a group. All remaining missing values were now imputed based on groups and empty cells were filled with a value of 38 as recommended.
Normalization
As recommended by the software user guide for screening studies, variability arising from differences in sample handling was minimized using global mean normalization with mean expression of all genes. Markers with Cq larger than 34 were not included as directed. Replicates were averaged and values were converted to relative quantities on the linear scale prior to log2 conversion.
Basic analysis
The processed miRNA data was analyzed using hierarchical clustering ( Fig. 1 ) and principal component analysis (Fig. 2) methods to visually interpret the differential expression between groups. The groups were noted to have sufficient differences for a more robust statistical significance analysis. The C28 and SARC were compared using a 2-tailed unpaired T-test and the resulting P-values were corrected for false discovery using the well documented Benjamini-Hochberg method (Fig. 3) .
Gene expression data
Expression data was obtained by hybridizing extracted RNA from samples to HumanHT-12 V4_0_R1 array platform from Illumina. Care was taken to obtain RNA aliquots of same harvested cells as with miRNA expression data.
Quality control
The mRNA expression data were loaded on GeneSpring® 12.5 GX (Agilent Technologies, Santa Clara, CA, USA). The data for all probes including those with missing values were included in the preprocessing steps. Quality assessments were done visually using various plots including PCA (Fig. 4) . All samples were found to be of high quality with intra-group correlation of expression data within 98-99% match.
Normalization
Normalization of the mRNA expression data was performed using the 'Quantile' normalization method available in GeneSpring and the data was log2 transformed to the mean of all samples before statistical analyses. 
Basic analysis
Since one objective of the study was to cross-compare significant miRNA expression within groups to their target mRNA expression, statistical significance test was performed between human chondrosarcoma (SARC) and chrondrocytes (C28) as with miRNA expression data.
Multiple testing corrections on nominal P-values were performed using Benjamini-Hochberg method (Fig. 5) . Predicted and validated gene targets for miRNAs were obtained from miRWalk database (http://www. umm.uni-heidelberg.de/apps/zmf/mirwalk/index.html). Gene expression data for targets of significant miRNAs were matched from the differential mRNA expression obtained above. 
Discussion
We describe here a unique miRNA and mRNA expression dataset from human chondrosarcoma (JJ012) and chondrocytes (C28) cell lines. This dataset comprises only array data from Exiqon miRNA array and Illumina mRNA array. The expression data submitted here is of highest quality and has been used in studies published recently [3] in journals with wide subscription and impact, therefore would benefit wider biomedical research through further sharing. 
